40 min listen
Bispecific Antibodies: The Case for Non-BCMA Targets
FromKeeping Current
ratings:
Length:
24 minutes
Released:
Jun 11, 2021
Format:
Podcast episode
Description
Join Dr Chari as he reviews the rationale and clinical evidence of novel non-BCMA-targeted bispecific antibodies for patients with R/R multiple myeloma. Credit available for this activity expires: 6/10/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/952772?src=mkm_podcast_addon_952772
Released:
Jun 11, 2021
Format:
Podcast episode
Titles in the series (100)
Implementing Multiple Myeloma Clinical Trial Data in Real-World Practice: Experts in the field discuss how to implement the newest data in multiple myeloma into the real-world clinical practice. --- Full URLs: Earn Credit / Learning Objectives & Disclosures:... by Keeping Current